Tuberculosis: Mechanisms, Pathogenesis and Treatment (A3)
Tuberculosis: Mechanisms, Pathogenesis and Treatment (A3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Jan 17 - 21, 2019 at Fairmont Banff Springs, Banff, Alberta, Canada.
Course Description :
The tuberculosis (TB) research and development landscape has seen many exciting breakthroughs over the past two decades. New diagnostics have emerged; innovative research has significantly reduced biological uncertainties; two novel drugs were launched; and public-private partnerships are dedicating massive efforts to dramatically shorten TB therapy, tackle resistant disease and discover new vaccines. Despite these achievements, TB remains the leading infectious disease cause of death globally. Meanwhile, shifts in funding priorities and a false sense of success could threaten the current focus and momentum, which would have catastrophic consequences. The broad themes covered in the main conference program and the three workshops will achieve the following aims: 1) To re-ignite collaborative and multidisciplinary research by bringing together experts in basic science, translational research, and drug discovery and development; 2) To bring together young brilliant minds and established investigators to encourage new discussions and the exchange of innovative ideas for strategies moving forward; and 3) To foster cross-fertilization at the interface between research and development, all aspects of which are critical if we are to tackle the TB pandemic and achieve the next innovation leap.
Plenary Session Topics:
• Pathogenic Strategies of Mycobacteria
• Workshop 1: Pediatric and Extrapulmonary TB
• Immune Responses to Mycobacterium Tuberculosis
• Host Cell Signaling and Invasion
• Workshop 2: TB Drug Targets and MOA
• Translation to the Treatment and Diagnosis of Disease
• Treatment and Diagnosis of Disease
• Molecular Dissection and Targeting of Mycobacterium Tuberculosis
• Exploiting Mycobacterial Vulnerabilities
• Panel: Careers in Biomedical Research
• Host Determinants of Disease Outcomes
Additional details will be posted as soon as they are available.
|Contact No.||:||+1 800-253-0685,
|Registration Type||End Date||Price|
|Conference Early Fee||20 Nov,2018||USD 945.00|
|Conference Regular Fee||16 Jan,2019||USD 1145.00|
|Student Early Fee||20 Nov,2018||USD 720.00|
|Student Regular Fee||16 Jan,2019||USD 920.00|